Bank Hapoalim BM Purchases 1,218 Shares of Synopsys, Inc. $SNPS

Posted by Francis Steltz on Jun 17th, 2026

Bank Hapoalim BM grew its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 79.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,757 shares of the semiconductor company’s stock after acquiring an additional 1,218 shares during the quarter. Bank Hapoalim BM’s holdings in Synopsys were worth $1,295,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in SNPS. Sowell Financial Services LLC boosted its stake in shares of Synopsys by 2.0% during the 4th quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after purchasing an additional 21 shares during the period. Natural Investments LLC raised its position in Synopsys by 4.6% in the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after purchasing an additional 21 shares during the period. Financial Management Professionals Inc. raised its position in Synopsys by 7.0% in the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after purchasing an additional 22 shares during the period. Foronjy Financial LLC lifted its stake in Synopsys by 5.2% in the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock worth $210,000 after purchasing an additional 22 shares during the last quarter. Finally, Barden Capital Management Inc. boosted its position in shares of Synopsys by 1.2% during the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after buying an additional 23 shares during the period. Institutional investors own 85.47% of the company’s stock.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

Positive Sentiment: Synopsys announced a collaboration with Murata Manufacturing that expands access to Murata simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, which could support broader product adoption and reinforce Synopsys’ software ecosystem. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
Neutral Sentiment: A DCF-based valuation article said SNPS appears “fairly valued” at about $394, suggesting the stock may not be dramatically undervalued despite recent weakness. SNPS Fairly Valued by DCF at $394
Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares for about $6.7 million, and CFO Shelagh Glaser also sold 3,394 shares for about $1.5 million. Both transactions were made under pre-arranged 10b5-1 plans, which makes them less alarming, but insider selling can still pressure sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Citigroup upped their target price on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Piper Sandler upped their price objective on Synopsys from $430.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, May 28th. HSBC lowered Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a research note on Friday, February 20th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $563.81.

Read Our Latest Report on SNPS

Synopsys Stock Performance

Synopsys stock opened at $448.38 on Wednesday. The company has a 50 day moving average price of $475.78 and a 200-day moving average price of $461.46. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a market capitalization of $85.86 billion, a PE ratio of 103.79, a P/E/G ratio of 2.67 and a beta of 1.22.

Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.